About Renalyx
Renalyx is a Healthcare company based in Bengaluru (India) founded in 2012 by Shyam Vasudeva Rao, and was acquired by Lords Mark in November 2025. Screening and disease management solutions for chronic kidney disease patients. Renalyx has raised $914.64 thousand across 4 funding rounds from investors including Lord's Mark, Canbank VC and Srinivasan Ramadorai. Its Indian entity Renalyx Health Systems Private Limited reported revenue of ₹2.70 Cr. Its focus areas include Life Sciences, Nephrology, Medical Devices and Therapeutic Devices.
Company details
Renalyx was founded in 2012 in Bengaluru, India, as a provider of technology solutions in the healthcare sector focused on chronic kidney disease. Operations include three products: Renalyx-Reach for rural CKD screening, Renalyx-Care as a disease management platform, and Renalyx-Treat for cost-effective dialysis. Partnerships are maintained with the School of Medical Science and Technology at IIT Kharagpur for dialysis membrane and eHealth research, along with eHealthenablers as a healthcare accelerator.
- Headquarters Bengaluru, India
- Founders Shyam Vasudeva Rao
- Stage Acquired
- SectorsHealthcare
- Website renalyx.com
- Social LinkedIn
- Acquired by Lords Mark (Nov 2025)
- Legal Name Renalyx Health Systems Private Limited.
- Date of Incorporation 29 Oct, 2012
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2.70 Cr
FY 2025 · +2% YoY
- Net Loss-₹2.56 Cr
FY 2025 · -95% margin
- EBITDA₹4.7 Lakh
FY 2025 · 2% margin
- Total Equity Funding$914.64K (USD)
in 4 rounds
- InvestorsLord's Mark
& 7 more
- Acquired byLords Mark
(Nov 2025)
Associated legal entities of Renalyx
Renalyx operates through Renalyx Health Systems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Renalyx Health Systems Private Limited CIN U74140KA2012PTC066472 | Active | 29 Oct 2012 | Bangalore, Karnataka | ₹2.7 Cr | 3 | View details |
Funding Insights of Renalyx
Renalyx has successfully raised a total of $914.64K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $914,641
- Total Rounds 4
- First Round $306,345
(Sep 2014)
- Investors Count 7
All 4 funding rounds of Renalyx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | Series A | – | – | ||
| Dec 2021 | $571,960 | Angel Round | – | Srinivasan Ramadorai | |
| Jul 2018 | $36,336 | Angel Round | – | Satyaprakash Krishna Rao | – |
| Sep 2014 | $306,345 | Angel Round | – | Satyaprakash Krishna Rao | – |
8 investors in total: 2 institutional and 6 angel.
Investors in Renalyx
Renalyx has secured backing from 8 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Lord's Mark, Canbank VC and Srinivasan Ramadorai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are managed for promising startups. | canbank.vc | Bengaluru, India | ||
Renewable energy products are manufactured by Lords Mark in India. | 1998 | lordsmark.com | Mumbai, India | |
SR Srinivasan Ramadorai | unknown_8f637d3af96948119 | |||
NS Nagarajan Srinivasan | unknown_19081455df034abd8 | |||
AS Anurag Srivastava | Angel investor, ex-Amazon leader, focused on tech startups in India | unknown_cebf9af227c749799 | ||
PG Pramod Gunjikar | unknown_0537071536ac4fb1a | |||
JR Jyothi Rn | unknown_9454313e6b8b4a3a9 | |||
SK Satyaprakash Krishna Rao | unknown_96c435b9182d4ccc9 |
Investor details for Renalyx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Renalyx Health Systems Private Limited (Renalyx)
Renalyx Health Systems Private Limited is the primary company behind Renalyx. The board of Renalyx Health Systems Private Limited currently have 3 directors; the longest-serving is Shyam Vasudevarao, appointed in 2016. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shyam Vasudevarao DIN 03094681 | Managing Director | 29 Feb 2016 | 10 yrs 7 mo | Renalyx Health Systems Private Limited |
| Manav Kishore Teli DIN 08797578 | Nominee Director | 11 Mar 2025 | 1 yr 7 mo | Renalyx Health Systems Private Limited |
| Subodh Chandra Gupta DIN 10478270 | Director | 13 Aug 2025 | 1 yr 2 mo | Renalyx Health Systems Private Limited |
People of Renalyx
6 people are tracked at Renalyx (2 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
Gopalkrishna Kalibhat | Engineering Head | Leadership |
Prathiksha Rajamurugan | Project Intern | Team |
Jayasimha G L | Senior Engineer | Team |
Pramodh H.r | Mechanical Manager | Team |
Sreehari H P | Software Manager | Team |
Complete people profiles for Renalyx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Renalyx
Figures of Renalyx Health Systems Private Limited, the primary company behind Renalyx, for FY 2025. Revenue was ₹2.70 Cr (+2% year on year). Net loss was -₹2.56 Cr (-95% margin). EBITDA was ₹4.7 Lakh (2% margin). Revenue has grown at a compounded annual rate of -12% over three years and +45% over five years.
- ₹2.70 CrRevenue · FY 2025 · +2% YoY
- -₹2.56 CrNet loss · -95% margin
- ₹4.7 LakhEBITDA · 2% margin
- ₹50.1 LakhPaid-up capital
- -12%Revenue CAGR, 3 years
- +45%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Renalyx Health Systems Private Limited are on its company page.
Detailed financial statements for Renalyx
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Renalyx
4 dated milestones of Renalyx across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Renalyx is founded.
- Funding First funding round of $306K.
- Funding Latest funding round, Series A,.
- Exit Acquired by Lords Mark.
Web traffic of Renalyx
The website of Renalyx (renalyx.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 4% vs previous month
Websites whose visitors overlap most with Renalyx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| coe-iot.com | 100% | 29.6K | #979,584 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Renalyx
Complete news archive for Renalyx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renalyx
Renalyx was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Renalyx is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Renalyx is a funded company, having raised a total of $914.64K across 4 funding rounds to date. The company's 1st funding round was a Angel Round of $306.35K, raised on Sep 2014.
The primary company behind Renalyx, Renalyx Health Systems Private Limited, reported revenue of ₹2.70 Cr for FY 2025, up 2% year on year.
Renalyx was founded in 2012 in Bengaluru, India, as a provider of technology solutions in the healthcare sector focused on chronic kidney disease. Operations include three products: Renalyx-Reach for rural CKD screening, Renalyx-Care as a disease management platform, and Renalyx-Treat for cost-effective dialysis. Partnerships are maintained with the School of Medical Science and Technology at IIT Kharagpur for dialysis membrane and eHealth research, along with eHealthenablers as a healthcare accelerator.
Renalyx has 8 investors. Key investors include Lord's Mark, Canbank VC, Srinivasan Ramadorai, Nagarajan Srinivasan, and Anurag Srivastava.
Renalyx operates through Renalyx Health Systems Private Limited.
Yes. Renalyx was acquired by Lords Mark in November 2025.
The legal entities of Renalyx currently have 3 directors, including Manav Kishore Teli, Shyam Vasudevarao, Subodh Chandra Gupta.